23 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
1433224	1	Structure-activity studies on benzhydrol-containing nipecotic acid and guvacine derivatives as potent, orally-active inhibitors of GABA uptake.	Warner-Lambert
2544727	1	Sodium channel binding and anticonvulsant activities for the enantiomers of a bicyclic 2,4-oxazolidinedione and monocyclic models.	University Of Alabama
2846842	14	Anticonvulsant activities of phenyl-substituted bicyclic 2,4-oxazolidinediones and monocyclic models. Comparison with binding to the neuronal voltage-dependent sodium channel.	University Of Alabama
15177465	18	2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.	Institut Henri Beaufour
10406642	8	Synthesis and preliminary biological evaluation of new alpha-amino amide anticonvulsants incorporating a dextromethorphan moiety.	Pharmacia & Upjohn
25927480	36	Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical Indications.	Merck Research Laboratories
25026046	42	Studies examining the relationship between the chemical structure of protoxin II and its activity on voltage gated sodium channels.	Purdue Pharma
19388676	21	Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into human clinical studies.	Johnson & Johnson Pharmaceutical Research & Development
9703475	19	Synthesis and pharmacological evaluation of N,N'-diarylguanidines as potent sodium channel blockers and anticonvulsant agents.	Cambridge Neuroscience
9685245	22	Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channels.	Cambridge Neuroscience
8295214	21	Synthesis and pharmacological evaluation of phenylacetamides as sodium-channel blockers.	Warner-Lambert
10571163	14	A novel class of Na+ and Ca2+ channel dual blockers with highly potent anti-ischemic effects.	Institute For Bio-Medical Research
10498200	40	Sodium channel activity and sigma binding of 2-aminopropanamide anticonvulsants.	Pharmacia & Upjohn
	15	Batrachotoxin binding site antagonists	TBA
21962108	14	Lactam-stabilized helical analogues of the analgesicµ-conotoxin KIIIA.	Monash University
18640044	24	Discovery and stereoselective synthesis of the novel isochroman neurokinin-1 receptor antagonist 'CJ-17,493'.	Pfizer
17724025	8	Structure/function characterization of micro-conotoxin KIIIA, an analgesic, nearly irreversible blocker of mammalian neuronal sodium channels.	University Of Utah
15080972	64	The design, preparation and SAR of novel small molecule sodium (Na(+)) channel blockers.	Arqule
8691482	25	A structure-activity relationship study of novel phenylacetamides which are sodium channel blockers.	Warner-Lambert